Filed: 2/9/2023ACC: 0001104659-23-014959
📋 What this filing means
SATURN V CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 19 equity positions with a total reported market value of $120.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
19
Positions
$120.51M
Total AUM (reported)
7.43M
Total Shares
Allocation by class
COMMON$106.88M88.7%
SPONSORED ADR$7.95M6.6%
SHS$5.68M4.7%
Portfolio Concentration
Top 3$30.64M25.4%
4–10$52.71M43.7%
11–25$37.17M30.8%
Top 3 weight
25.4%
Top 10 weight
69.2%
Voting Authority Distribution
Total shares with voting rights: 7.43M
Sole
Full voting authority
7.43M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole19
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings19
Rows:
CRINETICS PHARMACEUTICALS IN
SOLEShares623.82K
TypeSH
Market value$11.34M
9.41%
Sole
623.82K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares685K
TypeSH
Market value$9.89M
8.20%
Sole
685K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares212.33K
TypeSH
Market value$9.41M
7.81%
Sole
212.33K
Shared
0.00
None
0.00
ARCUTIS BIOTHERAPEUTICS INC
SOLEShares487.18K
TypeSH
Market value$8.79M
7.29%
Sole
487.18K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares196.98K
TypeSH
Market value$7.97M
6.62%
Sole
196.98K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares68.40K
TypeSH
Market value$7.95M
6.60%
Sole
68.40K
Shared
0.00
None
0.00
MORPHIC HLDG INC
SOLEShares269.83K
TypeSH
Market value$7.37M
6.12%
Sole
269.83K
Shared
0.00
None
0.00
ITEOS THERAPEUTICS INC
SOLEShares342.07K
TypeSH
Market value$7.03M
5.83%
Sole
342.07K
Shared
0.00
None
0.00
ALBIREO PHARMA INC
SOLEShares341.83K
TypeSH
Market value$6.86M
5.70%
Sole
341.83K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares423.18K
TypeSH
Market value$6.73M
5.58%
Sole
423.18K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares719.94K
TypeSH
Market value$6.70M
5.56%
Sole
719.94K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.61M
TypeSH
Market value$5.72M
4.75%
Sole
1.61M
Shared
0.00
None
0.00
HORIZON THERAPEUTICS PLC
SOLEShares69.17K
TypeSH
Market value$5.68M
4.71%
Sole
69.17K
Shared
0.00
None
0.00
SAGE THERAPEUTICS INC
SOLEShares156.09K
TypeSH
Market value$5.37M
4.45%
Sole
156.09K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares566.18K
TypeSH
Market value$4.89M
4.06%
Sole
566.18K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares340.16K
TypeSH
Market value$3.75M
3.11%
Sole
340.16K
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares7.66K
TypeSH
Market value$2.17M
1.80%
Sole
7.66K
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares169.49K
TypeSH
Market value$1.56M
1.29%
Sole
169.49K
Shared
0.00
None
0.00
THERAVANCE BIOPHARMA INC
SOLEShares141.34K
TypeSH
Market value$1.33M
1.11%
Sole
141.34K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CRINETICS PHARMACEUTICALS INSOLE | Common | 623.82K | SH | $11.34M 9.41% | 623.82K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | Common | 685K | SH | $9.89M 8.20% | 685K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | Common | 212.33K | SH | $9.41M 7.81% | 212.33K | 0.00 | 0.00 |
ARCUTIS BIOTHERAPEUTICS INCSOLE | Common | 487.18K | SH | $8.79M 7.29% | 487.18K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | Common | 196.98K | SH | $7.97M 6.62% | 196.98K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | Sponsored ADR | 68.40K | SH | $7.95M 6.60% | 68.40K | 0.00 | 0.00 |
MORPHIC HLDG INCSOLE | Common | 269.83K | SH | $7.37M 6.12% | 269.83K | 0.00 | 0.00 |
ITEOS THERAPEUTICS INCSOLE | Common | 342.07K | SH | $7.03M 5.83% | 342.07K | 0.00 | 0.00 |
ALBIREO PHARMA INCSOLE | Common | 341.83K | SH | $6.86M 5.70% | 341.83K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | Common | 423.18K | SH | $6.73M 5.58% | 423.18K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | Common | 719.94K | SH | $6.70M 5.56% | 719.94K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | Common | 1.61M | SH | $5.72M 4.75% | 1.61M | 0.00 | 0.00 |
HORIZON THERAPEUTICS PLCSOLE | SHS | 69.17K | SH | $5.68M 4.71% | 69.17K | 0.00 | 0.00 |
SAGE THERAPEUTICS INCSOLE | Common | 156.09K | SH | $5.37M 4.45% | 156.09K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | Common | 566.18K | SH | $4.89M 4.06% | 566.18K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | Common | 340.16K | SH | $3.75M 3.11% | 340.16K | 0.00 | 0.00 |
BIOGEN INCSOLE | Common | 7.66K | SH | $2.17M 1.80% | 7.66K | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | Common | 169.49K | SH | $1.56M 1.29% | 169.49K | 0.00 | 0.00 |
THERAVANCE BIOPHARMA INCSOLE | Common | 141.34K | SH | $1.33M 1.11% | 141.34K | 0.00 | 0.00 |